ProPhase Labs, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
ProPhase Labs, Inc. (PRPH) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$904.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-11-14
- ProPhase Labs, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$1.40M.
- ProPhase Labs, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $277.00K.
- ProPhase Labs, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $215.00K, a 99.49% decline year-over-year.
- ProPhase Labs, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$724.00K, a 1196.97% decline year-over-year.
- ProPhase Labs, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $2.73M.
- ProPhase Labs, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$1.22M.
- ProPhase Labs, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$1.26M, a 197.98% decline from fiscal 2014.
- ProPhase Labs, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $1.29M, a 20.83% increase from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2018-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$1.12M derived: sum of 2 quarters · filed 2018-11-14 | -$904.00K 10-Q · filed 2018-11-14 | -$1.63M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2018-06-30 | $277.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-20 | $492.00K 10-Q · filed 2018-08-20 | -$232.00K derived: sum of 3 quarters · filed 2018-08-20 | -$33.62M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2018-03-31 | $215.00K 10-Q/A · filed 2018-08-20 | $214.00K 10-Q · filed 2018-05-15 | -$509.00K derived: sum of 2 quarters · filed 2018-08-20 | -$33.89M derived: sum of 3 quarters · filed 2018-11-14 | -$39.41M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-12-31 | -$724.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | -$34.11M derived: sum of 2 quarters · filed 2018-11-14 | -$39.63M derived: sum of 3 quarters · filed 2018-11-14 | $2.73M 10-K/A · filed 2018-08-20 | |
| 2017-09-30 | -$33.38M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14 | -$38.90M derived: sum of 2 quarters · filed 2018-11-14 | $3.46M 10-Q · filed 2018-11-14 | $3.52M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | -$5.52M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | $36.84M 10-Q/A · filed 2018-08-20 | $36.91M derived: sum of 3 quarters · filed 2018-08-20 | $36.13M derived: sum of 4 quarters · filed 2018-08-20 | |
| 2017-03-31 | $42.36M 10-Q/A · filed 2018-08-20 | $42.42M derived: sum of 2 quarters · filed 2018-08-20 | $41.65M derived: sum of 3 quarters · filed 2018-08-20 | $40.34M derived: sum of 4 quarters · filed 2018-08-20 | |
| 2016-12-31 | $66.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | -$708.00K derived: sum of 2 quarters · filed 2018-08-20 | -$2.02M derived: sum of 3 quarters · filed 2018-08-20 | -$1.22M 10-K/A · filed 2018-08-20 | |
| 2016-09-30 | -$774.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-08-20 | -$2.08M derived: sum of 2 quarters · filed 2018-08-20 | -$1.29M 10-Q/A · filed 2018-08-20 | -$961.00K derived: sum of 4 quarters · filed 2018-08-20 | |
| 2016-06-30 | -$1.31M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | -$515.00K 10-Q/A · filed 2018-08-20 | -$187.00K derived: sum of 3 quarters · filed 2018-08-20 | -$2.61M derived: sum of 4 quarters · filed 2018-08-20 | |
| 2016-03-31 | $793.00K 10-Q/A · filed 2018-08-20 | $1.12M derived: sum of 2 quarters · filed 2018-08-20 | -$1.30M derived: sum of 3 quarters · filed 2018-08-20 | -$2.56M derived: sum of 4 quarters · filed 2018-08-20 | |
| 2015-12-31 | $328.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | -$2.10M derived: sum of 2 quarters · filed 2018-08-20 | -$3.36M derived: sum of 3 quarters · filed 2018-08-20 | -$1.26M 10-K/A · filed 2018-08-20 | |
| 2015-09-30 | -$2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$3.69M derived: sum of 2 quarters · filed 2016-11-14 | -$1.59M 10-Q · filed 2016-11-14 | -$3.62M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2015-06-30 | -$1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $835.00K 10-Q · filed 2016-08-11 | -$1.19M derived: sum of 3 quarters · filed 2017-02-24 | -$3.59M derived: sum of 4 quarters · filed 2017-02-24 | |
| 2015-03-31 | $2.10M 10-Q · filed 2016-05-13 | $68.00K derived: sum of 2 quarters · filed 2017-02-24 | -$2.33M derived: sum of 3 quarters · filed 2017-02-24 | -$498.00K derived: sum of 4 quarters · filed 2017-02-24 | |
| 2014-12-31 | -$2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$4.42M derived: sum of 2 quarters · filed 2017-02-24 | -$2.59M derived: sum of 3 quarters · filed 2017-02-24 | $1.29M 10-K · filed 2017-02-24 | |
| 2014-09-30 | -$2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$566.00K derived: sum of 2 quarters · filed 2015-11-13 | $3.31M 10-Q · filed 2015-11-13 | $4.20M derived: sum of 4 quarters · filed 2016-03-29 | |
| 2014-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $5.71M 10-Q · filed 2015-08-12 | $6.60M derived: sum of 3 quarters · filed 2016-03-29 | $3.29M derived: sum of 4 quarters · filed 2016-03-29 | |
| 2014-03-31 | $3.88M 10-Q · filed 2015-05-13 | $4.77M derived: sum of 2 quarters · filed 2016-03-29 | $1.46M derived: sum of 3 quarters · filed 2016-03-29 | $983.00K derived: sum of 4 quarters · filed 2016-03-29 | |
| 2013-12-31 | $887.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$2.42M derived: sum of 2 quarters · filed 2016-03-29 | -$2.90M derived: sum of 3 quarters · filed 2016-03-29 | $1.07M 10-K · filed 2016-03-29 | |
| 2013-09-30 | -$3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$3.79M derived: sum of 2 quarters · filed 2014-11-13 | $179.00K 10-Q · filed 2014-11-13 | -$1.06M derived: sum of 4 quarters · filed 2015-03-27 | |
| 2013-06-30 | -$478.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $3.49M 10-Q · filed 2014-08-12 | $2.24M derived: sum of 3 quarters · filed 2015-03-27 | -$552.00K derived: sum of 4 quarters · filed 2015-03-27 | |
| 2013-03-31 | $3.96M 10-Q · filed 2014-05-12 | $2.72M derived: sum of 2 quarters · filed 2015-03-27 | -$74.00K derived: sum of 3 quarters · filed 2015-03-27 | -$1.73M derived: sum of 4 quarters · filed 2015-03-27 | |
| 2012-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | -$4.04M derived: sum of 2 quarters · filed 2015-03-27 | -$5.70M derived: sum of 3 quarters · filed 2015-03-27 | -$4.97M 10-K · filed 2015-03-27 | |
| 2012-09-30 | -$2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$4.45M derived: sum of 2 quarters · filed 2013-11-13 | -$3.73M 10-Q · filed 2013-11-13 | -$2.80M derived: sum of 4 quarters · filed 2014-03-27 | |
| 2012-06-30 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$931.00K 10-Q · filed 2013-08-13 | -$6.00K derived: sum of 3 quarters · filed 2014-03-27 | -$4.13M derived: sum of 4 quarters · filed 2014-03-27 | |
| 2012-03-31 | $727.00K 10-Q · filed 2013-05-10 | $1.65M derived: sum of 2 quarters · filed 2014-03-27 | -$2.48M derived: sum of 3 quarters · filed 2014-03-27 | -$3.32M derived: sum of 4 quarters · filed 2014-03-27 | |
| 2011-12-31 | $925.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$3.20M derived: sum of 2 quarters · filed 2014-03-27 | -$4.04M derived: sum of 3 quarters · filed 2014-03-27 | -$2.69M 10-K · filed 2014-03-27 | |
| 2011-09-30 | -$4.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$4.97M derived: sum of 2 quarters · filed 2012-11-14 | -$3.62M 10-Q · filed 2012-11-14 | -$4.09M derived: sum of 4 quarters · filed 2013-03-28 | |
| 2011-06-30 | -$843.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $511.00K 10-Q · filed 2012-08-13 | $38.00K derived: sum of 3 quarters · filed 2013-03-28 | -$2.42M derived: sum of 4 quarters · filed 2013-03-28 | |
| 2011-03-31 | $1.35M 10-Q · filed 2012-05-11 | $881.00K derived: sum of 2 quarters · filed 2013-03-28 | -$1.58M derived: sum of 3 quarters · filed 2013-03-28 | ||
| 2010-12-31 | -$473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$2.93M derived: sum of 2 quarters · filed 2013-03-28 | -$4.57M 10-K · filed 2013-03-28 | ||
| 2010-09-30 | -$2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$4.10M 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | -$1.64M 10-Q · filed 2011-08-12 | ||||
| 2009-12-31 | $844.00K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |